Drug Type Oligonucleotide |
Synonyms- |
Target |
Action agonists |
Mechanism TLR9 agonists(Toll like receptor 9 agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Inflammation | Discovery | - | 20 Feb 2024 | |
Neoplasms | Discovery | - | 20 Feb 2024 |